Koers SpectraCure AB (publ) Nasdaq Stockholm
Aandelen
SE0007158118
Geavanceerde medische apparatuur & technologie
Omzet 2022 | - | Omzet 2023 | 318K 29,59K 27,33K | Marktkapitalisatie | 375 mln. 34,89 mln. 32,22 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -25 mln. -2,33 mln. -2,15 mln. | Nettowinst (verlies) 2023 | -20 mln. -1,86 mln. -1,72 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 90,48 mln. 8,42 mln. 7,78 mln. | Nettoliquiditeiten 2023 | 50,23 mln. 4,67 mln. 4,32 mln. | EV/omzet 2023 | 1.021 x |
K/w-verhouding 2022 |
-19,2
x | K/w-verhouding 2023 |
-18,3
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 77,13% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Masoud Khayyami
CEO | Chief Executive Officer | 61 | 07-01-10 |
Henrik Ljung
DFI | Director of Finance/CFO | 66 | 01-04-18 |
Kristina Holst
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 79 | 01-03-03 | |
Thomas Kramar
BRD | Director/Board Member | 70 | 01-01-22 |
Masoud Khayyami
CEO | Chief Executive Officer | 61 | 07-01-10 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,05% | 837 mln. | |
-18,44% | 260 mln. | |
-34,57% | 76,56 mln. |